FGFR2 mutation in 46,XY sex reversal with craniosynostosis.

  title={FGFR2 mutation in 46,XY sex reversal with craniosynostosis.},
  author={Stefan Bagheri-Fam and Makoto Ono and Li Li and Liang Zhao and Janelle Ryan and Raymond Lai and Yukako Katsura and Fernando J. Rossello and Peter Koopman and Gerd Scherer and Oliver Bartsch and Jacob V.P. Eswarakumar and Vincent R Harley},
  journal={Human molecular genetics},
  volume={24 23},
Patients with 46,XY gonadal dysgenesis (GD) exhibit genital anomalies, which range from hypospadias to complete male-to-female sex reversal. However, a molecular diagnosis is made in only 30% of cases. Heterozygous mutations in the human FGFR2 gene cause various craniosynostosis syndromes including Crouzon and Pfeiffer, but testicular defects were not reported. Here, we describe a patient whose features we would suggest represent a new FGFR2-related syndrome, craniosynostosis with XY male-to… 

Figures from this paper

Case Report: Novel Compound Heterozygotic Variants in PPP2R3C Gene Causing Syndromic 46, XY Gonadal Dysgenesis and Literature Review

Novel compound heterozygous variants in PPP2R3C cause specific syndromic 46, XY gonadal dysgenesis with multiple extragonadal anomalies, which broadened the pathogenic variants spectrum of PPP3C.

Identification of novel candidate genes for 46,XY disorders of sex development (DSD) using a C57BL/6J-YPOS mouse model

The use of a DSD-specific animal model improves variant interpretation by correlating human sequence variants with transcriptome variation.

FGFR2 mutations and associated clinical observations in two Chinese patients with Crouzon syndrome

The findings expand the mutation spectrum of FGFR2, and are valuable for genetic counseling in addition to prenatal diagnosis in patients with Crouzon syndrome.

Genetics of 46,XY gonadal dysgenesis.

Ovotesticular disorders of sex development (DSD) in FGF9 mouse models of human synostosis syndromes.

It is suggested that in humans, testis development is largely tolerant of deleterious FGF9 mutations which lead to skeletal defects, thus offering an explanation as to why XY DSDs are rare in patients with pathogenic F GF9 variants.

Monogenic forms of DSD: An update.

This review focuses on the main genomic findings of recent years, which consists of new candidate genes or loci for DSD as well as new reproductive phenotypes associated with genes that are well established to cause DSD.

PIN1 is a new therapeutic target of craniosynostosis

It is concluded that PIN1 enzyme activity is important for FGFR2‐induced RUNX2 activation and craniofacial suture morphogenesis and highlighted that juglone or other PIN1 inhibitors represent viable alternatives to surgical intervention for treatment of CS and other hyperostotic diseases.

Overexpression of Fgfr2c causes craniofacial bone hypoplasia and ameliorates craniosynostosis in the Crouzon mouse

It is demonstrated that the intricate balance of FGF signalling required for correct calvarial bone and suture morphogenesis, and that increasing the expression of the wild-type FGFR2c isoform could be a way to prevent or delay craniosynostosis progression, are demonstrated.

Rapidly Progressive Multisutural Craniosynostosis in a Patient With Jackson-Weiss Syndrome and a De Novo FGFR2 Pathogenic Variant

Using 3-dimensional modeling of the FGFR protein, it is provided evidence that this variant resulted in abnormal dimerization and constitutive activation of FGFR, leading to the Jackson-Weiss phenotype.

RETRACTED ARTICLE: Fetal methotrexate syndrome and Antley–Bixler syndrome should not be confused

Clinicians should not mistake fetal methotrexate syndrome with Antley–Bixler syndrome, but caution when administering teratogens to women of child-bearing age and robust contraceptive and family-planning advice are warranted.



Mutation screening in patients with syndromic craniosynostoses indicates that a limited number of recurrent FGFR2 mutations accounts for severe forms of Pfeiffer syndrome

Genotype-phenotype analyses based on a large cohort of 84 patients with clinical features of CS, PS or JW by direct sequencing of genomic DNA indicate that in spite of some overlap, PS and CS are preferentially accounted for by two distinct sets of FGFR2 mutations.

Exome sequencing for the diagnosis of 46,XY disorders of sex development.

Early identification of the genetic cause of a DSD will in many cases streamline and direct the clinical management of the patient, with more focused endocrine and imaging studies and better-informed surgical decisions.

Loss of Fgfr2 leads to partial XY sex reversal.

Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes

Six of the seven Pfeiffer syndrome patients share two missense mutations, which have also been reported in Crouzon syndrome, and point mutations in FGFR2 are reported in seven sporadic Pfeiffsers.

A Novel Mouse Fgfr2 Mutant, Hobbyhorse (hob), Exhibits Complete XY Gonadal Sex Reversal

A novel, constitutive allele of Fgfr2, hobbyhorse (hob), which was identified in an ENU-based forward genetic screen for novel testis-determining loci and exploited the consistent phenotype of this constitutive mutant by analysing MAPK signalling at the sex-d determining stage of gonad development, but no significant abnormalities in mutant embryos were detected.

Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis.

The spectrum of FGFR2 mutations causing craniosynostosis is wider than previously recognized but that, nevertheless, the IgIIIa/IIIc region represents a genuine mutation hotspot.

Absence of inactivating mutations and deletions in the DMRT1 and FGF9 genes in a large cohort of 46,XY patients with gonadal dysgenesis.

Clinical and molecular characterization of Rubinstein‐Taybi syndrome patients carrying distinct novel mutations of the EP300 gene

It is indicated that EP300‐related RSTS cases occur more frequently than previously thought (˜8% vs 3–5%); furthermore, the characterization of novel EP300 mutations in R STS patients will enhance the clinical practice and genotype–phenotype correlations.